Sector
PharmaceuticalsOpen
₹1,562.8Prev. Close
₹1,562.8Turnover(Lac.)
₹6.07Day's High
₹1,635Day's Low
₹1,562.852 Week's High
₹1,85452 Week's Low
₹513.15Book Value
₹473.93Face Value
₹10Mkt Cap (₹ Cr.)
1,043.26P/E
39.4EPS
39.67Divi. Yield
0.06Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.82 | 5.77 | 5.77 | 5.73 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 207.79 | 185.29 | 160.38 | 138.21 |
Net Worth | 213.61 | 191.06 | 166.15 | 143.94 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 203.66 | 226.32 | 136.32 | 111.22 |
yoy growth (%) | -10.01 | 66.01 | 22.56 | -7.1 |
Raw materials | -134.03 | -147.23 | -87.98 | -79.26 |
As % of sales | 65.8 | 65.05 | 64.53 | 71.26 |
Employee costs | -14.38 | -14.1 | -12.36 | -11.05 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 27.01 | 34.95 | 13.77 | 7.96 |
Depreciation | -6.02 | -5.88 | -5.57 | -5.79 |
Tax paid | -6.8 | -8.65 | -3.67 | -0.58 |
Working capital | -3.24 | 29.95 | 17.25 | -4.15 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -10.01 | 66.01 | 22.56 | -7.1 |
Op profit growth | -16.81 | 127.66 | 89.81 | -32.25 |
EBIT growth | -22.44 | 143.4 | 65.89 | -18.1 |
Net profit growth | -23.15 | 160.4 | 36.86 | 14.35 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 257.36 | 217.98 | 212.01 | 204.64 | 228.18 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 257.36 | 217.98 | 212.01 | 204.64 | 228.18 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 8.59 | 11.74 | 7.78 | 8.67 | 11.48 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,823.35 | 157.3 | 4,37,806.65 | 237.82 | 0.74 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,140.8 | 81.93 | 1,36,080.52 | 430 | 0.58 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,611.9 | 33.1 | 1,31,478.83 | 1,055.94 | 0.8 | 3,752.25 | 346.4 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,417 | 77.52 | 1,16,513.07 | 469 | 0.81 | 2,394 | 201.77 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,100.5 | 25.69 | 1,12,205.15 | 1,700.8 | 0.27 | 4,035.4 | 156.19 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Bharat Kumar R Desai
Executive Director
Hemang Jayendrabhai Shah
Non Executive Director
Shaileshkumar Ghabhawala
Independent Director
Zankhana Sheth
Independent Director
Mukesh Patel
Non Executive Director
Sanjay Shah
Company Sec. & Compli. Officer
Krutika Bhattbhatt
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Bharat Parenterals Ltd
Summary
Bharat Parenterals Ltd. was incorporated on Sep.92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics.In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.
Read More
The Bharat Parenterals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹1599 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bharat Parenterals Ltd is ₹1043.26 Cr. as of 06 Sep ‘24
The PE and PB ratios of Bharat Parenterals Ltd is 39.4 and 3.30 as of 06 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Bharat Parenterals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bharat Parenterals Ltd is ₹513.15 and ₹1854 as of 06 Sep ‘24
Bharat Parenterals Ltd's CAGR for 5 Years at 54.77%, 3 Years at 59.99%, 1 Year at 152.70%, 6 Month at 13.39%, 3 Month at 16.78% and 1 Month at -10.40%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice